top of page

Technology

Platforms

Medley Therapeutic’s genetic medicine platform aims to activate the dormant regenerative potential inherent in our DNA, while the advanced biologics platform targets the progressive conditions such as solid tumor cancers and organ fibrosis.
Asset 16_2x.png

Genetic Medicine Platform

Our proprietary genetic medicine platform based on IP licensed from Baylor College of Medicine and Texas Heart Institute represents a paradigm shift in therapeutic approach. Instead of merely treating symptoms, we aim to activate the body's innate regenerative capabilities to repair damaged organs by creating new cells and reversing fibrosis.

Asset 17_2x.png
Advanced Biologics Platform

Our in-house developed advanced biologics platform focuses on developing novel therapeutics with cutting edge modalities for fibrosis and solid tumor cancers, conditions with significant unmet medical needs and substantial market potential.

Pipeline

bottom of page